Newer Anti-TB Drugs
H5Content
Shorter oral Bedaquiline-containing MDR/RR-TB regimen
Learn about Shorter oral Bedaquiline-containing MDR/RR-TB regimen
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension
Understand conditions for Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension using the algorithm.
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria
- Understand the eligibility criteria for initiating treatment with shorter oral bedaquiline-containing regimens for multidrug-resistant (MDR) and rifampicin-resistant (RR) tuberculosis (TB) patients.
- Recognize the DST based inclusion criteria and other criteria.
Requirements from Institutions for the Establishment of Nodal DR-TB Centre
Understand the institutional requirements for establishing a Nodal Drug-Resistant Tuberculosis (DR-TB) Centre.
DR-TB Services Referral Linkage Scenario: Patient Notified from the Private Sector
DR-TB Services Referral Linkage Scenario 1: Patient Notified from the Private Sector
DR-TB Service Referral Linkages Scenario: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector
DR-TB Service Referral Linkages Scenario 3: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector